Fluorogenic approach to evaluating prodrug hydrolysis and stability in live cells

Area of Science:

• Bioconjugation Chemistry
• Cellular Imaging
• Prodrug Development

Background:

• Assessing ester prodrug stability and drug release in living cells is crucial for drug development.
• Existing methods may lack the sensitivity or real-time monitoring capabilities needed for dynamic cellular studies.
• Development of novel fluorogenic probes is required for efficient intracellular drug release studies.

Purpose of the Study:

• To develop and validate a novel fluorogenic probe for studying ester prodrug stability and release in living cells.
• To utilize a cell-membrane permeable Arg9 peptide for efficient delivery and intracellular retention of the probe.
• To compare the hydrolysis rates of different ester prodrug models within living cells.

Main Methods:

• Synthesis of 5-maleimide-fluorescein diesters using α-amino protected d-Val and l-Ala.
• Conjugation of fluorescein diesters with a cysteine-containing Arg9 peptide via thiol-ene click chemistry.
• Purification using High-Performance Liquid Chromatography (HPLC) and characterization by Matrix-Assisted Laser Desorption/Ionization-Time of Flight Mass Spectrometry (MALDI-TOF MS).
• Cellular uptake, hydrolysis, and fluorescence monitoring using fluorescence microscopy and flow cytometry in HeLa cells.

Main Results:

• Fluorescein diester-Arg9 conjugates were successfully synthesized and characterized.
• Fluorescence microscopy revealed rapid hydrolysis and fluorescein release from the l-Ala diester within 30 minutes in HeLa cells.
• The d-Val diester showed stability, with minimal fluorescence observed.
• Flow cytometry determined a hydrolysis half-life (t_1/2) of 15 minutes for the l-Ala diester.
• The Arg9 peptide facilitated efficient probe delivery and retained released fluorescein for accurate quantification.

Conclusions:

• The developed fluorogenic probe-Arg9 peptide conjugate is effective for real-time monitoring of ester prodrug hydrolysis and release in living cells.
• The probe system allows for efficient intracellular delivery and quantification of released drug metabolites.
• This approach offers a feasible platform for screening and optimizing prodrug structures in cellular models.